Prof. Dr. Mehmet Deniz AYLI

1. Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study

Yadigar S., Akgür S., Arslan F., Sezen M., Özcan B., Ayaz E. Y., et al.

BMC Nephrology , cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)

2. Impact of crush syndrome severity on clinical outcomes after the earthquakes in southeastern Türkiye

Turgutalp K., Ozturk S., Koc N. S., Dolarslan M. E., KOÇYİĞİT İ., TURGUT D., et al.

BMC Nephrology , cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)

3. Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy

Kazan S., Öztürk S., Uzerk Kibar M., Ozcan S. G., Alcelik Karacan R. D., EREN N., et al.

Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

4. Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort

ÖZDEDE M., Yadigar S., GÜVEN A. T., Akgür S., Arslan F., Sezen M., et al.

Clinical Kidney Journal , cilt.19, sa.8, 2026 (SCI-Expanded, Scopus)

5. Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study

GÜVEN A. T., Yadigar S., ÖZDEDE M., Akgür S., Arslan F., Sezen M., et al.

Journal of Clinical Medicine , cilt.15, sa.15, 2026 (SCI-Expanded, Scopus)

6. Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry

Guven Taymez D., Uk E., EREN N., Kıykım A. A., DİNÇER M. T., Pınar M., et al.

Journal of Clinical Medicine , cilt.15, sa.11, 2026 (SCI-Expanded, Scopus)

7. Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients

Aylı B. I., ULUSAL OKYAY G., AYLI M. D.

Seminars in Dialysis , cilt.39, sa.3, ss.105-115, 2026 (SCI-Expanded, Scopus)

8. The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical Presentations

Ozturk S., Sumnu A., EREN N., DİNÇER M. T., UZUN S., Suleymanova V., et al.

Nephrology , cilt.31, sa.3, 2026 (SCI-Expanded, Scopus)

9. Prognostic Differences Between P190 and P210 BCR::ABL1 in Patients with Philadelphia-Positive B-cell Acute Lymphoblastic Leukemia

Pepeler M., Oztürk F., Okumus N., Dal M., Yaman S., Can F., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.42, sa.1, ss.110-119, 2026 (SCI-Expanded, Scopus)

10. Prognostic Implications of Serum C3 Levels in Primary Membranous Nephropathy: A Retrospective Cohort Analysis Implicaciones Pronósticas de los Niveles Séricos de C3 en la Nefropatía Membranosa Primaria: Un Análisis de Cohorte Retrospectivo

Onan E., UÇAR A. S., ORUÇ A., Doksan M., EREN N., KARADAĞ S., et al.

Revista de Nefrologia, Dialisis y Trasplante , cilt.46, sa.1, ss.12-25, 2026 (SCI-Expanded, Scopus)

11. Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry

Yadigar S., Akgür S., Güvenç T. S., Sezen M., Özcan B., Yıldırım Ayaz E., et al.

Cardiovascular Drugs and Therapy , 2026 (SCI-Expanded, Scopus)

12. Neuro-otological findings in fabry disease: prominent oculomotor dysfunction and selective vestibular involvement

Saygı Uysal G., Özdoğan A., ATILGAN K. G., ÖZLÜGEDİK S., AYLI M. D.

European Archives of Oto-Rhino-Laryngology , 2026 (SCI-Expanded, Scopus)

13. The role of complement C3 deposition in ANCA-associated glomerulonephritis: a registry-based study of clinical, histopathological, and prognostic insights

UZUN S., GÖK OĞUZ E., YILDIZ A., DERİCİ Ü., Cankaya E., ŞAHİN G., et al.

BMC Nephrology , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

14. De Novo Malignancies After Kidney Transplant: Where Do We Stand and Does the Head and Neck Region Require More Caution?

ULUSAL OKYAY G., AYERDEN EBİNÇ F., ATILGAN K. G., ALPER M., KARAMÜRSEL S., SELEN T., et al.

Experimental and Clinical Transplantation , cilt.23, sa.9, ss.604-611, 2025 (SCI-Expanded, Scopus)

15. EVALUATION OF CLINICAL AND PATHOLOGICAL FINDINGS AND TREATMENT OUTCOMES OF PATIENTS WITH LUPUS NEPHRITIS: A SINGLE CENTRE EXPERIENCE LUPUS NEFRİTLİ HASTALARIN KLİNİK VE PATOLOJİK BULGULARININ DEĞERLENDİRİLMESİ VE TEDAVİ SONUÇLARI: TEK MERKEZ DENEYİMİ

Duran B., AKÇAY Ö. F., AYHAN E. A., GÖK OĞUZ E., AYLI M. D.

Istanbul Tip Fakultesi Dergisi , cilt.88, sa.1, ss.1-8, 2025 (ESCI, Scopus, TRDizin)

16. Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey

Ozturk I., Gungor O., Ozturk S., Olmaz R., Keskin A. J. G., KOÇYİĞİT İ., et al.

Journal of Nephrology , cilt.37, sa.9, ss.2589-2599, 2024 (SCI-Expanded, Scopus)

17. Patients with crush syndrome and kidney disease: lessons learned from the earthquake in Kahramanmaraş, Türkiye

Ozturk S., TUĞLULAR Z. S., Olmaz R., KOÇYİĞİT İ., Kibar M. U., Turgutalp K., et al.

Kidney International , cilt.106, sa.5, ss.771-776, 2024 (SCI-Expanded, Scopus)

18. Biopsy-proven BK virus nephropathy in renal transplant recipients: A multi-central study from Turkey (BK-TURK STUDY)

Gungor O., Dheir H., Islam M., Toz H., YILDIZ A., Sinangil A., et al.

Clinical Nephrology , cilt.102, sa.4, ss.202-211, 2024 (SCI-Expanded, Scopus)

19. Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients

Yasar E., YILDIZ Y., Ozturk E., GÖK OĞUZ E., Coskun Yenigun E., Ozturk R., et al.

Nephrology , cilt.29, sa.7, ss.405-414, 2024 (SCI-Expanded, Scopus)

20. Coexistence of steroid-resistant minimal change disease and familial Mediterranean fever: A case report Coexistencia de enfermedad de cambios mínimos resistente a esteroides y fiebre Mediterránea familiar: Informe de un caso

Intas K., SELEN T., ULUSAL OKYAY G., AYHAN E. A., AYLI M. D.

Nefrologia , cilt.44, sa.3, ss.448-450, 2024 (Scopus)

21. A case with Joubert syndrome diagnosed at an advanced age Un caso de síndrome de Joubert diagnosticado a una edad avanzada

Intas K., ULUSAL OKYAY G., AYLI M. D.

Medicina Clinica , cilt.162, sa.7, ss.357-358, 2024 (SCI-Expanded, Scopus)

22. Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group

ORUÇ A., ŞUMNU A., Turkmen A., BAŞTÜRK T., CEBECİ E., Turgutalp K., et al.

Renal Failure , cilt.46, sa.1, 2024 (SCI-Expanded, Scopus)

23. The relationship between depression, anxiety, quality of life levels, and the chronic kidney disease stage in the autosomal dominant polycystic kidney disease

Yarlioglu A. M., GÖK OĞUZ E., Gundogmus A. G., ATILGAN K. G., Sahin H., AYLI M. D.

International Urology and Nephrology , cilt.55, sa.4, ss.983-992, 2023 (SCI-Expanded, Scopus)

24. Plasma Exchange in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Analysis

GÖK OĞUZ E., PAYDAŞ S., Hasbal N. B., TURGUT D., Şahin H., KAYA B., et al.

Turkish Journal of Nephrology , cilt.31, sa.4, ss.307-313, 2022 (Scopus, TRDizin)

25. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection

Buyukdemirci S., GÖK OĞUZ E., Cimen S. G., Sahin H., ÇİMEN S., AYLI M. D.

World Journal of Transplantation , cilt.12, sa.9, ss.299-309, 2022 (Scopus)

26. Predictive value of neutrophil-to-lymphocyte ratio in terms of need for intensive care unit and mortality in maintenance hemodialysis patients with COVID-19

GÖK OĞUZ E., YETER H. H., AKÇAY Ö. F., Besli S., SELEN T., DERİCİ Ü., et al.

Hemodialysis International , cilt.26, sa.3, ss.377-385, 2022 (SCI-Expanded, Scopus)

27. The Longitudinal Evolution of Post–COVID-19 Outcomes Among Hemodialysis Patients in Turkey

Ozturk S., Turgutalp K., ARICI M., GÖRGÜLÜ N., Tonbul H. Z., EREN N., et al.

Kidney International Reports , cilt.7, sa.6, ss.1393-1405, 2022 (SCI-Expanded, Scopus)

28. Clinicopathological Features and Kidney Survival in Rapidly Progressive Glomerulonephritis: A Single-Center Experience

Eksin M. A., GÖK OĞUZ E., ATILGAN K. G., Şahin H., SELEN T., ULUSAL OKYAY G., et al.

Turkish Journal of Nephrology , cilt.31, sa.2, ss.138-147, 2022 (Scopus, TRDizin)

29. Dismal Prognosis of Acute Allergic Tubulointerstitial Nephritis in Patients with AA Amyloidosis

YILDIRIM T., GÖK OĞUZ E., Koc N. S., Uzerk-Kibar M., ÜNER M., AYHAN E. A., et al.

Nephron , cilt.146, sa.2, ss.172-178, 2022 (SCI-Expanded, Scopus)

30. Pregnancy and its outcomes in hemodialysis patients in Turkey

Dheir H., Güngör Ö., Ulu S., GÖK OĞUZ E., EREN N., Altunören O., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.2, ss.354-360, 2022 (SCI-Expanded, Scopus, TRDizin)

31. COVID-19 Infection in Peritoneal Dialysis Patients: A Comparative Outcome Study with Patients on Hemodialysis and Patients without Kidney Disease

KAZANCIOĞLU R., ÖZTÜRK S., Turgutalp K., GÜRSU M., ARICI M., ORUÇ A., et al.

Turkish Journal of Nephrology , cilt.31, sa.1, ss.33-42, 2022 (Scopus, TRDizin)

32. Comparison of geriatric nutritional risk index and creatinine index in short-term mortality prediction in maintenance hemodialysis patients

AYERDEN EBİNÇ F., ULUSAL OKYAY G., DEĞER S. M., Şahin H., SELEN T., Kanar Doğan Ç., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.3, ss.641-648, 2022 (SCI-Expanded, Scopus, TRDizin)

33. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study

Ozturk S., Turgutalp K., ARICI M., GÖK M., Islam M., ALTIPARMAK M. R., et al.

International Journal of Clinical Practice , cilt.75, sa.9, 2021 (SCI-Expanded, Scopus)

34. Is dialysis adequacy a useful predictor for sexual function in males and females with end-stage renal disease? ¿Es la adecuación de diálisis un útil predictor para la función sexual en varones y mujeres con enfermedad renal en etapa terminal?

Selvi I., SARIKAYA S., ATILGAN K. G., AYLI M. D.

Revista Internacional de Andrologia , cilt.19, sa.3, ss.164-176, 2021 (SCI-Expanded, Scopus)

35. The impact of arteriovenous fistulas and tunneled cuffed venous catheters on morbidity and mortality in hemodialysis patients: A single center experience

Celik S., GÖK OĞUZ E., ULUSAL OKYAY G., SELEN T., AYLI M. D.

International Journal of Artificial Organs , cilt.44, sa.4, ss.229-236, 2021 (SCI-Expanded, Scopus)

36. The reliability and success of peritoneal dialysis during the COVID-19 pandemic

YETER H. H., GÖK OĞUZ E., AKÇAY Ö. F., Karaer R., Yasar E., DURANAY M., et al.

Seminars in Dialysis , cilt.34, sa.2, ss.147-156, 2021 (SCI-Expanded, Scopus)

37. Could L-carnitine treatment have a protective role in the cognitive function of patients undergoing hemodialysis?

ATILGAN K. G., Yalçındağ A., ÖRSEL S., AYLI M. D.

Turkish Journal of Nephrology , cilt.30, sa.1, ss.77-83, 2021 (ESCI, Scopus, TRDizin)

38. A practical diagnostic view to primary hyperaldosteronism for nephrology practice

AYERDEN EBİNÇ F., ULUSAL OKYAY G., AYLI M. D.

Turkish Journal of Nephrology , cilt.30, sa.2, ss.186-192, 2021 (ESCI, Scopus, TRDizin)

39. Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML

Ucar M., Ozet G., Koyuncu M., SÖNMEZ M., Akidan O., AYLI M. D., et al.

European Review for Medical and Pharmacological Sciences , cilt.25, sa.21, ss.6557-6565, 2021 (SCI-Expanded, Scopus)

40. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: A nationwide analysis from Turkey

ÖZTÜRK S., Turgutalp K., ARICI M., Odabas A. R., ALTIPARMAK M. R., AYDIN Z., et al.

Nephrology Dialysis Transplantation , cilt.35, sa.12, ss.2083-2095, 2021 (SCI-Expanded, Scopus)

41. COVID-19 infection in a kidney transplant recipient—special emphasis on pharmacokinetic interactions: A case report

GÖK OĞUZ E., ATILGAN K. G., Cimen S. G., Sahin H., SELEN T., AYERDEN EBİNÇ F., et al.

World Journal of Transplantation , cilt.10, sa.11, ss.365-371, 2020 (Scopus)

42. Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa

Tas-Aygar G., GÖNÜL M., ÖZCAN İ., AYLI M. D., Ertoy-Baydar D.

Dermatologic Therapy , cilt.33, sa.6, 2020 (SCI-Expanded, Scopus)

43. Clinical course of kidney donors in the long term after transplant: A single-center experience

ATILGAN K. G., AYLI M. D.

Turkish Journal of Nephrology , cilt.29, sa.3, ss.226-231, 2020 (ESCI, Scopus, TRDizin)

44. Listening to music during arteriovenous fistula surgery alleviates anxiety: A randomized single-blind clinical trial

Cimen S. G., GÖK OĞUZ E., Gundogmus A. G., ÇİMEN S., Sandikci F., AYLI M. D.

World Journal of Transplantation , cilt.10, sa.4, ss.79-89, 2020 (Scopus)

45. Retrospective analysis of clinical data and treatment of primary focal segmental glomerulosclerosis patients Análisis retrospectivo de datos clÍnicos y tratamiento de pacientes con glomeruloesclerosis segmentaria focal primaria

Karakurt N., GÖK OĞUZ E., Yayar O., Sahin H., AYLI M. D.

Revista de Nefrologia, Dialisis y Trasplante , cilt.39, sa.4, ss.249-262, 2019 (SCI-Expanded, Scopus)

46. Successful treatment of posttransplant recurrent complement C3 glomerulopathy with eculizumab

Sahin H., GÖK OĞUZ E., AKOĞLU H., Atilgan G., ULUSAL OKYAY G., Gursoy G. K., et al.

Iranian Journal of Kidney Diseases , cilt.12, sa.5, ss.315-318, 2018 (SCI-Expanded, Scopus)

47. Analysis of clinical and laboratory findings of secondary amyloidosis Sekonder Amiloidozda Klinik ve Laboratuvar Bulgularının Analizi

ATILGAN K. G., Odabaş A. R., DEDE F., AYLI M. D.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.27, sa.3, ss.267-271, 2018 (Scopus, TRDizin)

48. The effect of Helicobacter pylori eradication on proteinuria in patients with primary glomerulonephritis

DEDE F., AYLI M. D., Gonul I., Yuksel O., Ozturk R., Yildiz A., et al.

Archives of Medical Science , cilt.11, sa.4, ss.764-769, 2015 (SCI-Expanded, Scopus)

49. Contribution of High Flux Membranes to the Therapy of Uremia-Associated Dyslipidemia

Azak A., Huddam B., Öneç K., Koçak G., DEDE F., AYLI M. D., et al.

Therapeutic Apheresis and Dialysis , cilt.16, sa.6, ss.595-599, 2012 (SCI-Expanded, Scopus)

50. Modulation of the immune response to HBV vaccination by hemodialysis membranes

DEDE F., YIldIz A., AYLI M. D., Çolak N., Odabaş A. R., AKOĞLU H., et al.

International Urology and Nephrology , cilt.42, sa.4, ss.1069-1075, 2010 (SCI-Expanded, Scopus)

51. Psoriasis related membranous glomerulonephritis: Case report Psöriyazise eşlik eden membranöz glomerülonefrit

DEDE F., AYLI M. D., Yildiz A., IŞIK GÖNÜL İ., Kayataş M., Odabaş A. R.

Turkiye Klinikleri Journal of Medical Sciences , cilt.29, sa.6, ss.1716-1719, 2009 (SCI-Expanded, Scopus)

52. Effective treatment administration of cyclophosphamide in membranous nephropathy

DEDE F., AYLI M. D., Sahiner S.

Journal of Nephrology , cilt.21, sa.4, ss.560-565, 2008 (SCI-Expanded, Scopus)

53. Acute tubulo-interstitiel nephritis associated with diffuse large B-cell lymphoma presenting as acute renal failure

DEDE F., Yilmaz B., AYLI M. D., Kayataş M., Atilgan G., Caner S., et al.

Renal Failure , cilt.30, sa.4, ss.465-467, 2008 (SCI-Expanded, Scopus)

54. Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions

DEDE F., Onec B., AYLI M. D., Gonul I. I., Onec K.

Scandinavian Journal of Urology and Nephrology , cilt.42, sa.2, ss.178-180, 2008 (SCI-Expanded, Scopus)

55. Pauci-immune glomerulonephritis associated with primary antiphospholipid syndrome

DEDE F., ŞİMŞEK Y., Odabas A. R., AYLI M. D., Kayatas M.

Rheumatology International , cilt.28, sa.5, ss.499-501, 2008 (SCI-Expanded, Scopus)

56. Propylthiouracil-induced vasculitis associated with ANCA: A case report

Yuksel C., AYLI M. D., Yuksel A., ATILGAN K. G., DEDE F., Guler S., et al.

Renal Failure , cilt.29, sa.2, ss.235-237, 2007 (SCI-Expanded, Scopus)

57. Efficient treatment of crescentric glomerulonephritis associated with hepatitis B virus with lamivudin in a case referred with acute renal failure [17]

DEDE F., AYLI M. D.

Nephrology Dialysis Transplantation , cilt.21, sa.12, ss.3613-3614, 2006 (SCI-Expanded, Scopus)

58. Glomerulonephritis associating parvovirus B19 infection

ÖNGÜRÜ P., DEDE F., BODUR H., AYLI M. D., AKINCI E., Cevik M., et al.

Renal Failure , cilt.28, sa.1, ss.85-88, 2006 (SCI-Expanded, Scopus)

59. Focal segmental glomerulosclerosis associating Kimura disease

DEDE F., AYLI M. D., ATILGAN K. G., Yüksel C., DURANAY M., Şener D., et al.

Renal Failure , cilt.27, sa.3, ss.353-355, 2005 (Scopus)

60. The effect of high-flux hemodialysis on dialysis-associated amyloidosis

AYLI M., AYLI M. D., Azak A., Yüksel C., Atilgan G., DEDE F., et al.

Renal Failure , cilt.27, sa.1, ss.31-34, 2005 (SCI-Expanded, Scopus)

61. The effect of high-flux hemodialysis on renal anemia

AYLI M. D., AYLI M., Azak A., Yüksel C., Koşmaz G. P., Atilgan G., et al.

Journal of Nephrology , cilt.17, sa.5, ss.701-706, 2004 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim